China-based Sino Biological, a biotech company specializing in research reagents and contract research services concluded its acquisition of Vancouver-based SignalChem Biotech (SCB) in a deal valued at $48M. SCB focuses on bioactive enzymes, including kinases, proteases, phosphatases, ubiquitin, and epigenetic enzymes. Over the past two decades, SCB has established proprietary production and quality control platforms, setting industry standards for the development and production of high-quality ...